Literature DB >> 16368978

Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease.

Shingo Yamanishi1, Tadasu Iizumi, Eri Watanabe, Masumi Shimizu, Shigeru Kamiya, Kumiko Nagata, Yoshihiro Kumagai, Yoshitaka Fukunaga, Hidemi Takahashi.   

Abstract

Besides various gastroduodenal diseases, Helicobacter pylori infection may be involved in autoimmune disorders like rheumatoid arthritis (RA) or idiopathic thrombocytopenic purpura. Such autoimmune disorders are often associated with autoreactive antibodies produced by B-1 cells, a subpopulation of B lymphocytes. These B-1 cells are mainly located in the pleural cavity or mucosal compartment. The existence of H. pylori urease-specific immunoglobulin A (IgA)-producing B cells in the mucosal compartment and of their specific IgM in the sera of acutely infected volunteers suggests the possibility that urease stimulates mucosal innate immune responses. Here, we show for the first time that purified H. pylori urease predominantly stimulates the B-1-cell population rather than B-2 cells, which produce antigen-specific conventional antibodies among splenic B220(+) B cells. The fact that such stimulation of B-1 cells was not affected by the addition of polymyxin B indicates that the effect of purified H. pylori urease was not due to the contamination with bacterial lipopolysaccharide. Furthermore, the production of various B-1-cell-related autoreactive antibodies such as IgM-type rheumatoid factor, anti-single-stranded DNA antibody, and anti-phosphatidyl choline antibody was observed when the splenic B cells were stimulated with purified H. pylori urease in vitro. These findings suggest that H. pylori components, urease in particular, may be among the environmental triggers that initiate various autoimmune diseases via producing autoreactive antibodies through the activation of B-1 cells. The findings shown here offer important new insights into the pathogenesis of autoimmune disorders related to H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368978      PMCID: PMC1346662          DOI: 10.1128/IAI.74.1.248-256.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Differential development of progenitor activity for three B-cell lineages.

Authors:  A B Kantor; A M Stall; S Adams; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  A new nomenclature for B cells.

Authors:  A Kantor
Journal:  Immunol Today       Date:  1991-11

3.  Idiotypic multireactivity of 'natural' antibodies. 'Natural' anti-idiotypes also inhibit helper cells with cross-reactive clonotypes.

Authors:  P M Araujo; D Holmberg; C Martinez-A; A Coutinho
Journal:  Scand J Immunol       Date:  1987-05       Impact factor: 3.487

4.  Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets.

Authors:  K A Eaton; C L Brooks; D R Morgan; S Krakowka
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

5.  Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.

Authors:  H Takahashi; Y Nakagawa; K Yokomuro; J A Berzofsky
Journal:  Int Immunol       Date:  1993-08       Impact factor: 4.823

6.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations.

Authors:  K Nagata; T Mizuta; Y Tonokatu; Y Fukuda; H Okamura; T Hayashi; T Shimoyama; T Tamura
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  B cells expressing CD5 are increased in Sjögren's syndrome.

Authors:  M Dauphinée; Z Tovar; N Talal
Journal:  Arthritis Rheum       Date:  1988-05

10.  Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression.

Authors:  L W Arnold; C A Pennell; S K McCray; S H Clarke
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies.

Authors:  Masataka Kuwana; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review.

Authors:  Donald M Arnold; Ashley Bernotas; Ishac Nazi; Roberto Stasi; Masataka Kuwana; Yang Liu; John G Kelton; Mark A Crowther
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

Review 3.  Role of Helicobacter pylori infection in autoimmune diseases.

Authors:  Sarfaraz Ahmed Hasni
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

4.  Production of autoantibodies by murine B-1a cells stimulated with Helicobacter pylori urease through toll-like receptor 2 signaling.

Authors:  Fumiko Kobayashi; Eri Watanabe; Yohko Nakagawa; Shingo Yamanishi; Yoshihiko Norose; Yoshitaka Fukunaga; Hidemi Takahashi
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 5.  Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases.

Authors:  Mislav Radić
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 6.  Helicobacter pylori infection and extragastric disorders in children: a critical update.

Authors:  Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?

Authors:  Mislav Radić; Dušanka Martinović Kaliterna; Damir Bonacin; Jadranka Morović Vergles; Josipa Radić; Damir Fabijanić; Vedran Kovačić
Journal:  Rheumatol Int       Date:  2012-12-06       Impact factor: 2.631

8.  Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura.

Authors:  Yanyan Bai; Zhaoyue Wang; Xia Bai; Ziqiang Yu; Lijuan Cao; Wei Zhang; Changgeng Ruan
Journal:  Int J Hematol       Date:  2009-01-30       Impact factor: 2.490

Review 9.  Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms.

Authors:  Masataka Kuwana
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 10.  Helicobacter pylori and autoimmune disease: cause or bystander.

Authors:  Daniel S Smyk; Andreas L Koutsoumpas; Maria G Mytilinaiou; Eirini I Rigopoulou; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.